Dexzyle is a workflow and communication layer, not a competing chart. It surfaces resident, order, and document context from the systems your facilities, pharmacies, and providers already run.
Use as many or as few of these integrations as you like — each one is switched on for your organization during onboarding, not built as a project. Dexzyle uses the resident, medication-order, document, and facility data your systems already provide, so your teams avoid duplicate clinical data entry.
Dexzyle integrates with PointClickCare to sync residents and facilities and to surface provider-review context—resident details, medications and orders, progress notes, observations, and practitioners—where the integration is enabled for your organization. Resident-chart filing can send secure-message text and shared attachments, including faxes, where enabled for your organization.
Electronic feeds bring admissions, discharges, transfers, and pharmacy medication-order activity into Dexzyle by organization and facility. Resident movement appears in the Encounters screen with per-resident details and date filters, while medication-order feeds power the current pharmacy order stream in Rx Messages.
Where configured, Dexzyle surfaces available DocuTrack metadata by Rx number and within resident context, connecting it with electronic medication-order activity and RxTimeline. Underlying prescription-document access is available only when explicitly confirmed for your organization.
Inbound and outbound fax runs on a provider-agnostic foundation, currently implemented with InterFAX. Faxes can be archived and shared into secure conversations, and fax attachments can be filed through the resident-chart workflow where enabled for your organization.
Integrations are enabled per organization and confirmed during onboarding. Availability of specific data types depends on your systems and agreements.
We’ll show how resident, medication-order, document, fax, and communication context come together—without replacing the systems your teams rely on.